吉林敖东(000623)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000623 吉林敖东

已收盘 02-27 15:00:00

{"stockData":{"symbol":"000623","market":"SZ","secType":"STK","nameCN":"吉林敖东","latestPrice":19.03,"timestamp":1772175780000,"preClose":18.83,"halted":0,"volume":10280387,"delay":0,"changeRate":0.0106,"floatShares":1191000000,"shares":1196000000,"eps":2.1472,"marketStatus":"已收盘","change":0.2,"latestTime":"02-27 15:00:00","open":18.83,"high":19.03,"low":18.77,"amount":194000000,"amplitude":0.0138,"askPrice":19.04,"askSize":344,"bidPrice":19.03,"bidSize":673,"shortable":0,"etf":0,"ttmEps":2.1472,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":5,"adr":0,"adjPreClose":18.83,"symbolType":"stock","openAndCloseTimeList":[[1772155800000,1772163000000],[1772168400000,1772175600000]],"highLimit":20.71,"lowLimit":16.95,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1195895387,"isCdr":false,"pbRate":0.74,"roa":"--","peRate":8.862705,"roe":"7.56%","epsLYR":1.3179,"committee":0.351331,"marketValue":22758000000,"turnoverRate":0.0086,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-02。","floatMarketCap":22665000000},"requestUrl":"/m/hq/s/000623/wiki","defaultTab":"wiki","newsList":[{"id":"2614653705","title":"吉林敖东：积极推进医药营销改革","url":"https://stock-news.laohu8.com/highlight/detail?id=2614653705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614653705?lang=zh_cn&edition=full","pubTime":"2026-02-25 15:27","pubTimestamp":1772004433,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东02月25日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年7月，腾讯健康与康美药业签署战略合作协议后，经营有了较好改观。请问吉林敖东是否有引进有先进经营理念的战略合作者的想法？目前公司正积极推进医药营销改革，通过整合各营销板块、组建营销事业群，优化管理体系、形成发展合力、统一资源，实现营销突破，助力公司高质量发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500018642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623","BK0028","BK0074","BK1161","BK0239","BK0012","09939","BK1574","BK0188","BK0086","BK0201","BK1515","159938"],"gpt_icon":0},{"id":"2613138727","title":"吉林敖东（000623）披露控股子公司获10个中药配方颗粒上市备案凭证，2月24日股价上涨1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613138727","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613138727?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:25","pubTimestamp":1771932335,"startTime":"0","endTime":"0","summary":"吉林敖东药业集团股份有限公司近日披露《关于控股子公司获得中药配方颗粒上市备案凭证的自愿性信息披露公告》。公告显示，公司控股子公司吉林敖东延边药业股份有限公司近日获得10个中药配方颗粒上市备案凭证，涉及龙葵、天葵子、醋艾炭等产品。截至目前，延边药业已累计获得535个中药配方颗粒上市备案凭证。该事项对公司拓展中药配方颗粒业务具有重要意义，有助于增强企业核心竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400039140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0086","BK0239","BK0028","000623","BK0012","BK0201","BK0074"],"gpt_icon":0},{"id":"2610948699","title":"吉林敖东(000623.SZ)子公司获得10个中药配方颗粒上市备案凭证","url":"https://stock-news.laohu8.com/highlight/detail?id=2610948699","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610948699?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:19","pubTimestamp":1770884375,"startTime":"0","endTime":"0","summary":"智通财经APP讯，吉林敖东(000623.SZ)发布公告，近日，公司控股子公司吉林敖东延边药业股份有限公司(以下简称“延边药业”)获得10个《中药配方颗粒上市备案凭证》。延边药业作为公司核心层企业，在中药领域具有一定优势，截至本公告刊登之日已累计获得535个《中药配方颗粒上市备案凭证》，对公司拓展中药配方颗粒业务具有重要意义，为公司持续发展创造了有利条件，进一步增强了企业的核心竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0086","BK0028","BK0012","000623","BK0074","BK0188","BK0201","BK0239"],"gpt_icon":0},{"id":"2608823005","title":"吉林敖东：公司主营业务经营稳健，整体基本面稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=2608823005","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608823005?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:21","pubTimestamp":1770106865,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东02月03日在投资者关系平台上答复投资者关心的问题。公司主要的盈利来自广发证券的投资受益、分红。公司2025年业绩预告系综合全年经营、投资收益等因素测算，业绩取得大幅增长主要原因是公司公允价值变动收益及投资收益同比增加。公司主营业务经营稳健，整体基本面稳定，未发生重大变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300026581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0074","BK0086","BK0012","BK0028","BK0201","000623","BK0188"],"gpt_icon":0},{"id":"2608823123","title":"吉林敖东：聚焦医药主业，持续推进产品创新研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2608823123","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608823123?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:12","pubTimestamp":1770106338,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东02月03日在投资者关系平台上答复投资者关心的问题。希望公司领导层好好考虑转型创新药相关事宜。公司高度关注医药行业集采常态化及创新药发展趋势，聚焦医药主业，持续推进产品创新研发，并通过产业基金布局生物制药等创新领域。公司将结合医药全产业链优势，科学统筹研发投入，审慎评估创新药研发方向与布局节奏，稳步推进研发工作，持续提升公司核心竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300025618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK1161","BK0012","BK0086","BK0239","159938","BK1574","BK1515","BK0074","BK0188","BK0201","000623","09939"],"gpt_icon":0},{"id":"2608851903","title":"2月2日吉林敖东跌7.63%，汇添富中证中药ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608851903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608851903?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:47","pubTimestamp":1770022034,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日吉林敖东跌7.63%创60日新低，收盘报18.88元，换手率4.24%，成交量50.48万手，成交额9.77亿元。重仓吉林敖东的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为汇添富基金的汇添富中证中药ETF。汇添富中证中药ETF目前规模为24.52亿元，最新净值1.0471，较上一交易日下跌1.1%，近一年上涨0.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0028","560080","BK0012","000623","159647","BK0074","BK0188","BK0201","BK0239"],"gpt_icon":0},{"id":"2608856107","title":"吉林敖东：坚持“医药健康 + 金融资本”双轮驱动战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2608856107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608856107?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:09","pubTimestamp":1770019753,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东02月02日在投资者关系平台上答复投资者关心的问题。真心建议公司处理掉医药业务，把公司打造成一个专门投资的公司。敖东投资、敖东控股吉林敖东回复：尊敬的投资者：您好！公司坚持“医药健康 + 金融资本”双轮驱动战略，公司拥有深厚的医药产业积淀、成熟的产品矩阵及稳固的市场竞争力，是公司实现可持续发展的根基。未来公司将持续深化产融协同，力争以稳健业绩回报广大投资者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200020720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623","BK0239","BK0028","BK0201","BK0086","BK0012","BK0188","BK0074"],"gpt_icon":0},{"id":"2608588190","title":"股市必读：吉林敖东（000623）预计2025年全年每股收益盈利:1.93元至2.12元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608588190","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608588190?lang=zh_cn&edition=full","pubTime":"2026-02-02 04:36","pubTimestamp":1769978171,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，吉林敖东报收于20.44元，下跌1.68%，换手率1.6%，成交量19.05万手，成交额3.9亿元。吉林敖东发布业绩预告，预计2025年全年归属净利润盈利22.65亿元至24.82亿元。公司公告汇总2025年度业绩预告吉林敖东预计2025年度归属于上市公司股东的净利润为226,503.39万元至248,222.90万元，同比增长46.00%至60.00%；扣除非经常性损益后的净利润为206,934.46万元至228,653.97万元，同比增长31.56%至45.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0012","BK0028","BK0201","BK0188","000623","BK0239","BK0086"],"gpt_icon":0},{"id":"2606654784","title":"吉林敖东：2026年暂无股票回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2606654784","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606654784?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:51","pubTimestamp":1769518275,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东01月26日在投资者关系平台上答复投资者关心的问题。谢谢吉林敖东回复：尊敬的投资者：您好！公司已于2025年2月完成2024年-2025年度股份回购计划，投入金额4.2亿元，累计回购2,351.38万股,占公司总股本1.97%。在股份回购方面，2020年至2025年公司累计支付11.4亿元，先后实施四次股份回购，并注销4,517.40万股。2026年，公司暂无股票回购计划，后续若有相关安排，将严格履行法定决策程序并及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700039509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0188","000623","BK0086","BK0239","BK0201","BK0074"],"gpt_icon":0},{"id":"2606247598","title":"股市必读：吉林敖东（000623）1月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606247598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606247598?lang=zh_cn&edition=full","pubTime":"2026-01-27 01:08","pubTimestamp":1769447297,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，吉林敖东报收于20.75元，上涨1.12%，换手率1.79%，成交量21.34万手，成交额4.43亿元。或者是继续加大对辽宁成大的投资计划？截至目前，公司及子公司延边药业合计持有辽宁成大103,625,476股，占辽宁成大总股本的6.77%，后续若有达到信息披露标准的事项将及时履行信息披露义务。当日关注点来自交易信息汇总：1月26日主力资金净流入3267.35万元，显示主力对个股的积极介入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700001266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0201","BK0239","BK0028","BK0074","BK0012","BK0086","000623"],"gpt_icon":0},{"id":"2606929764","title":"吉林敖东：公司暂无对禾元生物的投资计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2606929764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606929764?lang=zh_cn&edition=full","pubTime":"2026-01-26 15:45","pubTimestamp":1769413518,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东01月26日在投资者关系平台上答复投资者关心的问题。或者是继续加大对辽宁成大的投资计划？谢谢吉林敖东回复：尊敬的投资者：您好！公司暂无对禾元生物的投资计划。截至目前，公司及子公司延边药业合计持有辽宁成大103,625,476股，占辽宁成大总股本的6.77%，后续若有达到信息披露标准的事项将及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600015104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000623","BK0188","BK0086","688765","BK0201","BK0074","BK0028","BK0012"],"gpt_icon":0},{"id":"2604972315","title":"股市必读：吉林敖东（000623）1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604972315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604972315?lang=zh_cn&edition=full","pubTime":"2026-01-19 04:06","pubTimestamp":1768766770,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，吉林敖东报收于20.09元，下跌0.35%，换手率1.2%，成交量14.34万手，成交额2.89亿元。董秘最新回复投资者： 您好董秘，请问公司有没有在AI医药或AI健康领域的布局及成果？公司积极关注AI与医药及健康领域深度融合带来的产业变革。交易信息汇总资金流向1月16日主力资金净流出143.39万元；游资资金净流入1303.51万元；散户资金净流出1160.11万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900001532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0239","BK0201","BK0012","BK0028","BK0086","BK0188","000623"],"gpt_icon":0},{"id":"2603951749","title":"吉林敖东：智能化驱动医药全产业链升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2603951749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603951749?lang=zh_cn&edition=full","pubTime":"2026-01-16 20:52","pubTimestamp":1768567945,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东01月16日在投资者关系平台上答复投资者关心的问题。公司积极关注AI与医药及健康领域深度融合带来的产业变革。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600038785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","159938","09939","BK0012","BK0074","BK0086","BK0201","BK0239","BK1574","BK0028","BK1515","BK0188","000623"],"gpt_icon":0},{"id":"2600206098","title":"每周股票复盘：吉林敖东（000623）发生大宗交易成交353.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600206098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600206098?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:43","pubTimestamp":1767382989,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，吉林敖东（000623）报收于19.53元，较上周的19.82元下跌1.46%。本周，吉林敖东12月29日盘中最高价报19.89元。12月31日盘中最低价报19.49元。吉林敖东当前最新总市值233.56亿元，在中药板块市值排名11/67，在两市A股市值排名840/5181。本周关注点交易信息汇总：12月29日吉林敖东发生1笔大宗交易，成交金额353.05万元交易信息汇总12月29日吉林敖东发生1笔大宗交易，成交金额353.05万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0074","BK0086","BK0201","BK0239","BK0028","BK0188","000623"],"gpt_icon":0},{"id":"2595127727","title":"流感疫情持续，防控系统工程再受考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2595127727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595127727?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:18","pubTimestamp":1767172695,"startTime":"0","endTime":"0","summary":"2025年末，全国流感疫情持续处于高流行水平。产业链协同响应，构建多层次供应保障流感防控是一项系统工程，需要疫苗预防、快速诊断、药物治疗等多个环节的有效衔接。本轮疫情中，上市药企正通过全产业链布局，搭建从源头预防到终端治疗的健康保障网络。中成药在本轮疫情中表现活跃。公司表示，金振口服液四季度市场需求回暖，正加紧排产满足市场需要。随着该产品儿童流感新适应症的获批，其在儿科领域的应用场景进一步拓宽。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025123100030908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000623","BK0060","000756","BK0114","688276","BK0185","BK0077","BK0096","BK0175","BK0186","002393","300937","BK0239","002603","BK0046","BK0196","002317","603882","BK0197","600566","BK0010","603858","600557","000999","BK0164","BK0188","BK0201","BK0236","BK0074","BK0086","BK0012","BK0284","BK0042","BK0146","SG9999001069.SGD","002728","BK0097","BK0250","BK0070","300244","301207","BK0183","600079","BK0187"],"gpt_icon":0},{"id":"2595732700","title":"股市必读：12月29日吉林敖东发生1笔大宗交易 成交金额353.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595732700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595732700?lang=zh_cn&edition=full","pubTime":"2025-12-30 02:24","pubTimestamp":1767032652,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，吉林敖东报收于19.62元，下跌1.01%，换手率0.81%，成交量9.7万手，成交额1.92亿元。当日关注点来自交易信息汇总：12月29日主力资金净流出785.53万元，散户资金净流入838.34万元。大宗交易12月29日吉林敖东发生1笔大宗交易，成交金额353.05万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000001310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0074","BK0086","BK0239","BK0201","000623","BK0188","BK0012"],"gpt_icon":0},{"id":"2593536490","title":"吉林敖东：智能化+工业化驱动全产业链升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2593536490","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593536490?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:51","pubTimestamp":1766494291,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东12月22日在投资者关系平台上答复投资者关心的问题。公司聚焦医药主业发展，在中药配方颗粒等重点项目建设上，配备智能控制系统，生产设备和关键环节网络全覆盖，实现生产质控信息化、数字化、智能化，以“智能化+工业化”驱动全产业链升级，推动人工智能技术在医药全产业链的场景创新，公司子公司延边药业为吉林省智能制造示范工厂。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300037556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0201","BK0239","BK0028","BK0074","BK0012","BK0086","000623"],"gpt_icon":0},{"id":"2590509859","title":"吉林敖东：智能化驱动全产业链升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2590509859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590509859?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:51","pubTimestamp":1765543900,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东12月11日在投资者关系平台上答复投资者关心的问题。我已经持有敖东十年以上了，是敖东的忠实粉丝。未来，公司将根据市场变化和经营需求，综合运用多种工具优化股东回报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200037981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0201","BK0028","BK0074","000623","BK0012","BK0086","BK0239"],"gpt_icon":0},{"id":"2589818011","title":"吉林敖东（000623）披露公司员工持股计划延期，12月5日股价上涨1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589818011","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589818011?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:23","pubTimestamp":1764944607,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，吉林敖东报收于19.49元，较前一交易日上涨1.19%，最新总市值为233.08亿元。近日，吉林敖东发布关于公司员工持股计划延期的公告。公告显示，公司于2025年12月5日召开第十一届董事会第二十二次会议，审议通过《关于公司员工持股计划延期的议案》，同意将公司第一期员工持股计划存续期延长12个月，即延长至2026年12月8日。本次延期经员工持股计划持有人代表大会审议通过，代表份额占总额的100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623","BK0074","BK0028","BK0086","BK0188","BK0012","BK0239","BK0201"],"gpt_icon":0},{"id":"2586735209","title":"吉林敖东：磷酸奥司他韦产销正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2586735209","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586735209?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:21","pubTimestamp":1764314483,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东11月28日在投资者关系平台上答复投资者关心的问题。公司生产的磷酸奥司他韦胶囊当前产销正常，能够满足流感高发期的市场需求。其中，小儿柴桂退热口服液适用于儿童发热症状、感冒清热胶囊覆盖普通感冒需求、磷酸奥司他韦胶囊适用于病毒感冒，流感高发期间，公司通过全产业链布局保障产能，保障百姓用药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800016532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","BK0074","BK0028","BK0188","BK0012","BK0201","000623"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772360207394,"stockEarnings":[{"period":"1week","weight":0.032},{"period":"1month","weight":-0.0811},{"period":"3month","weight":-0.0037},{"period":"6month","weight":-0.0614},{"period":"1year","weight":0.1761},{"period":"ytd","weight":-0.0256}],"compareEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.0028},{"period":"3month","weight":0.0705},{"period":"6month","weight":0.079},{"period":"1year","weight":0.2287},{"period":"ytd","weight":0.0489}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"吉林敖东药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"61216人(较上一季度减少7.18%)","perCapita":"19456股","listingDate":"1996-10-28","address":"吉林省延边朝鲜族自治州敦化市敖东大街2158号","registeredCapital":"119589万元","survey":"　　吉林敖东药业集团股份有限公司的主营业务是中药、化学药品研发、制造和销售。公司的主要产品是中药、化学药品、连锁药店批发、零售。凭借卓越的综合实力和行业影响力，公司连续十余年荣登中国制药工业百强榜单，2024中国中药研发实力排行榜TOP50中药榜第26位，并跻身“中国500最具价值品牌”，资产质量稳居行业前列。","listedPrice":7.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉林敖东(000623)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉林敖东(000623)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉林敖东,000623,吉林敖东股票,吉林敖东股票老虎,吉林敖东股票老虎国际,吉林敖东行情,吉林敖东股票行情,吉林敖东股价,吉林敖东股市,吉林敖东股票价格,吉林敖东股票交易,吉林敖东股票购买,吉林敖东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉林敖东(000623)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉林敖东(000623)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}